Wealthcare Advisory Partners’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,413
Closed -$212K 582
2022
Q1
$212K Buy
5,413
+468
+9% +$18.2K 0.01% 507
2021
Q4
$227K Buy
+4,945
New +$236K 0.01% 513
2020
Q1
Sell
-300
Closed -$10K 1514
2019
Q4
$10K Sell
300
-2,000
-87% -$67.7K ﹤0.01% 936
2019
Q3
$74K Sell
2,300
-200
-8% -$6.84K 0.01% 456
2019
Q2
$86K Hold
2,500
0.01% 406
2019
Q1
$84K Sell
2,500
-850
-25% -$26.8K 0.01% 364
2018
Q4
$93K Sell
3,350
-1,050
-24% -$32.6K 0.02% 318
2018
Q3
$169K Buy
4,400
+600
+16% +$22.1K 0.03% 250
2018
Q2
$133K Buy
3,800
+2,400
+171% +$83.7K 0.03% 278
2018
Q1
$47K Buy
+1,400
New +$47.7K 0.01% 407

Other funds holding FFTY

Wealthcare Advisory Partners's FFTY Position: Q2 2022 in Review

Wealthcare Advisory Partners sold out of CapForce IBD 50 ETF (FFTY) in Q2 2022, closing a stake of 5,413 shares — an estimated $212K sold.

Wealthcare Advisory Partners first reported a position in FFTY in Q1 2018 and held it in 10 quarters. The position peaked at $227K in Q4 2021. 58 funds tracked by Wall St. Rank hold FFTY as of Q2 2022.

  • Wealthcare Advisory Partners reported no remaining CapForce IBD 50 ETF position as of Q2 2022 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 5,413 CapForce IBD 50 ETF shares in Q2 2022, an estimated $212K.
  • Wealthcare Advisory Partners first reported a position in CapForce IBD 50 ETF in Q1 2018 and held it in 10 quarters.
  • Wealthcare Advisory Partners's CapForce IBD 50 ETF position peaked at $227K in Q4 2021.
  • 58 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2022.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2022, filed 15 Aug 2022.